search
Parkinson
Trends
- 1Undisclosed paraquat safety data emerges amid Syngenta Parkinson's lawsuits●Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US. Syngenta denies kee
Chemical maker Syngenta is facing Parkinson's disease lawsuits in the United States, and undisclosed safety data about its weedkiller paraquat is now coming to light. The company denies withholding relevant information from the EPA. Paraquat remains on the US market even though it has been banned in many other countries over health concerns.
- 2
The Los Angeles Rams and Denver Broncos met in Week 3 on Sunday Night Football, with a disputed pass interference penalty becoming the game's flashpoint — it wiped out what would have been a Rams interception at a major turning point. Attention also sits on injuries: a Rams starting cornerback was carted off with a shoulder issue, while Colby Parkinson (knee) and Marvin Mims Jr. (foot) were both listed questionable before kickoff.
- 3Researchers Develop Real-Time Monitoring for Parkinson's Treatments●Researchers develop technology for real-time monitoring of Parkinson's treatments
Researchers have developed technology that allows real-time monitoring of Parkinson's disease treatments, according to The Korea Times. The system could let doctors track how patients respond to medication as it happens, potentially improving how therapy is adjusted for the progressive neurological disorder, which affects millions worldwide and currently relies largely on subjective symptom assessment.
- 4AbbVie wins FDA approval for new Parkinson's drug Juvmo●AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo
AbbVie has received US Food and Drug Administration approval for Juvmo, described as a next-generation treatment for Parkinson's disease. The decision adds a new option to AbbVie's neurology portfolio and gives patients and doctors an additional therapy for managing the progressive movement disorder.
- 5FDA approves AbbVie's Parkinson's drug from Cerevel deal●AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
AbbVie has won US Food and Drug Administration approval for a Parkinson's disease treatment developed through its $8.7 billion acquisition of Cerevel Therapeutics. The approval validates the company's large bet on neurology and gives AbbVie a new product in a market where its flagship franchise faces eventual competition. Industry observers are watching how quickly the drug can reach patients and generate revenue.
- 6World Parkinson Congress 2026 Sets Out Key Scientific Themes▼World Parkinson Congress 2026: Key Scientific Themes
The World Parkinson Congress has outlined the key scientific themes for its 2026 edition, according to the American Parkinson Disease Association. The themes point to where researchers and clinicians expect progress in understanding and treating Parkinson's disease. Patients, caregivers and scientists are following the announcement for what it signals about the direction of Parkinson's research ahead of the congress.
- 7Yale Researchers Target Misfolded Proteins to Prevent Parkinson's●Managing Misfolded Proteins to Prevent Parkinson’s Disease
Researchers at Yale School of Medicine are highlighting the role of misfolded proteins in the development of Parkinson's disease, arguing that better management of these protein build-ups could help prevent the condition. Misfolded alpha-synuclein proteins are a known hallmark of Parkinson's, and approaches that clear or stabilise them are an active area of research into halting the disease before symptoms progress.
- 8Anaesthetist says AI helped find drug link behind mother's illness●A positive use of AI. An anaesthetist used AI to review medical journals and was able to hypothesise that a drug for Par
An anaesthetist reports that after using AI to review medical journals, he hypothesised that a drug taken for Parkinson's disease had caused a vitamin B6 deficiency in his dying mother. Once the vitamin was administered, she began to recover. He stresses that further study is needed, and the anecdote is drawing attention as an example of AI assisting medical insight.
- 9Parkinson and Chen Advance at Big West Fall Selection Event▼Parkinson, Chen Advance at Big West Fall Selection Event
Two University of California, Irvine tennis players, Parkinson and Chen, have advanced at the Big West Fall Selection Event, according to UCI Athletics. The university's athletic department announced the result, though specific match scores, opponents and round details were not provided. It marks a positive early result for the Anteaters program during the fall tennis season.
- 10Son used AI to help save his mother's life from Parkinson's●Son who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients https://www.bbc.co.uk/ne
A son says artificial intelligence helped him find the medical insight needed to save his mother's life, and he now hopes the case can provide clues for other Parkinson's disease patients. The story highlights how AI tools are increasingly being used by families alongside doctors to explore treatment options for complex neurological conditions.
- 11Muhammad Ali's secret 1996 Olympic torch moment, 30 years on▼Muhammad Ali was the Olympics' best-kept secret. 30 years later, the women who knew remember the gasp
Muhammad Ali's lighting of the Olympic cauldron at the 1996 Atlanta Games was kept secret even from many insiders. Thirty years later, the women who helped orchestrate the surprise are recalling the moment the stadium gasped as the boxing legend, battling Parkinson's disease, raised the torch. Their accounts shed new light on one of the most emotional scenes in Olympic history and why organizers worked so hard to protect the secret until the last second.
- 12Former Championship star says Phil Parkinson wrong for Wrexham▼Former Championship star slams Wrexham boss Phil Parkinson: “Not the man to lead them to the Premier League”
A former Championship player has publicly criticised Wrexham manager Phil Parkinson, saying he is "not the man to lead them to the Premier League". The remarks add pressure on Parkinson as Wrexham continue their push up the English football pyramid amid heavy attention on the club's ambitious ownership project. Debate over whether the experienced boss is the right fit for their top-flight ambitions is now dividing supporters.
- 13Michael J. Fox documentary draws praise from reviewers▼“Still: A Michael J. Fox Movie” is a profound, captivating documentary
Reviews of "Still: A Michael J. Fox Movie" describe the documentary about the actor's life and battle with Parkinson's disease as profound and captivating. The film revisits Fox's rise to fame and his decades living with his diagnosis, and critics are calling it a moving, honest portrait of the beloved star.
- 14Saved By the Bell star Dennis Haskins dies at 75 after Parkinson's battle▼‘Saved By the Bell’ star Dennis Haskins battled Parkinson’s disease before death at 75
Dennis Haskins, best known for playing Principal Richard Belding on the sitcom 'Saved By the Bell', has died at the age of 75. According to reports, he had been battling Parkinson's disease before his death. Fans and former castmates are remembering the actor, whose role made him a familiar figure to generations of television viewers.